Entergy's Nuclear-Powered Dividend

04/25/2011 3:01 pm EST

Focus: STOCKS

Roger Conrad

Founder and Chief Editor, Capitalist Times

This efficient utility’s 5% yield is a gift despite regional opposition to its nuclear plants, writes Roger Conrad, editor of Utility Forecaster.

Entergy (ETR) owns two nuclear power plants in the final stage of winning an operating license extension from the Nuclear Regulatory Commission (NRC), including the Indian Point plant upriver from New York City.

It also owns four “boiling water” nukes, the same type struck last month in Japan by an earthquake measuring 9.0 on the Richter scale, as well as the ensuing 50-foot-high tsunami.

That’s why it’s no surprise that Entergy shares have plunged from the mid-70s into the 60s since the Fukushima reactors’ woes began. But its wealth-building potential is very much intact.

Entergy’s key is consistent, strong operating performance. Last month, the NRC extended the license of the Vermont Yankee nuclear plant over fierce opposition from the state government, no doubt noting the operating-rate boost from 78% to 94% since Entergy bought it.

The company’s ten nuclear plants delivered a record 94.1% operating rate in 2010.

Entergy’s finest hour was in the wake of Hurricane Katrina, which wiped out its home city of New Orleans. Standard & Poor’s recently acknowledged its rebuilding effort by boosting the Big Easy unit’s credit rating to BBB.

Safety costs are likely to rise at US nuclear plants. And while a 50-foot tsunami would wipe out New York City long before it reached Indian Point, New York Governor Andrew Cuomo will oppose re-licensing. Such are the dysfunctional politics of nuclear power.

Entergy, however, is set for earnings of $6.35 to $6.85 per share this year, and 6% to 8% annual growth thereafter. Throw in the 4.9% dividend, and that’s 11% to 13% annual returns.

Buy Entergy up to $80. [Shares traded below $69 Monday—Editor.]

Subscribe to Utility Forecaster here...

Related Reading:

Related Articles on STOCKS

Keyword Image
11 Reasons to Buy Microsoft
9 hours ago

For our latest recommendation, we revisit one of the world's most prominent technology companies, Mi...

Keyword Image
A Trio of Top-Tier Biotechs
9 hours ago

We hold three biotech stocks in our growth portfolio — Biogen (BIIB), Bioverativ (BIVV), and R...

Keyword Image
Saudis, Oil and ETFs
9 hours ago

Under the guise of clamping down on “widespread corruption,” Prince Mohammed bin Salman ...